1.The survival duration and prognostic factors after surgical treatment of gastric cancer
Journal of Practical Medicine 2004;478(4):50-52
The cross-sectional descriptive study was performed at Hospital K from January 1995 to December 1999 on 171 patients with gastric cancer. Among them, 110 had had fully information about their status. 31% had got 5 years old survival ability with the mean survival duration of 40 months. Post operative prognostic significant factors: the level of invasion of tumor, 5 years old survival ability minimized progressively from T1 to T4 reached 100%, 39%, 18% and 0%, glandular metastasis and distant meastasis which affected to survival duration; the tumor of a size < 5cm had got better prognosis versus that of > 5cm of size and 10cm of size; prognosis was better with higher differentiated type of cells than those of lower defferentiated type; prognosis was better in intestinal type than in dispersing type. The age, the gender, the weight loss were not related to postoperative survival duration.
Stomach Neoplasms
;
Surgery
;
Therapeutics
3.Reconstruction oesophageal-intestinal condinuity after total gastrectomy
Journal Ho Chi Minh Medical 2004;8(2):125-127
The prevelence of gastric cancer in population is different according to areas but ingeneral, it is more likely in all countries. Surgery is the main treatment. Treatable surgery is gastrectomy. There are 2 different views in cutting total gastrectomy i.e. total gastrectomy based on rules and total gastrectomy by requests. There are many reconstruction oesophageal-intestinal condinuity in total gastrectomy in order to response 1 or 2 aims as follows: To create 1 sac instead of cut gastrectomy, to make patients eat more, their health will be better; Foods is intested by natural physiological route, through duodenum to small intestine in order to produce more bile liquid and pancreatic juice during digestion
Stomach Neoplasms
;
Therapeutics
;
surgery
;
gastrectomy
4.Diagnosis and surgical treatment of relapsed gastric cancer.
Journal of Practical Medicine 2002;435(11):8-10
A study on 24 patients with the relapsed gastric cancer /764 patients with gastric cancer operated in ViÖt §øc Hospital during 1993-1997 has shown that the number of the relapsed gastric cancer account for 3,1% total number of operation for gastric cancer. 38,3% patients received the second operation within the first 6 - 24 month of the first operation. 70,8% patients found the invasive tumor vegetation in connective edge. Only 16,7% patients found non- invasive relapsed cancer in connective edge., short cut (20,8%); biopsy testing operation and jejunum-open for eating (12,5%); biopsy testing operation (37,5%).The post operative mortality rate(12,5%).
Stomach Neoplasms
;
Diagnosis
;
therapeutics
;
surgery
5.Esophago-intestinal anastomotic leakage after total gastrectomy in gastric cancer
Journal of Practical Medicine 2002;435(11):35-37
149 patients with gastric epithelioma indicated the total gastrectomy in the army central hospital 108 during 1994-2000. The esophago-intestinal anastomotic leakage, a severe complication occurred in 2 patients among group received the esophago-intestinal anastomosis as method of omega. There was no this complication in group received the operation as method of lygidakis (making the false stomach). This study indicated that technique of anastomosis played an important role in the esophago-intestinal anastomotic leakage.
Stomach Neoplasms
;
complications
;
surgery
;
therapeutics
9.Some remarks on lymph node dissection and recovering of gastrointestinal circulation after gastrectomy caused by cancer at B15 department of Military Central Hospital N.108
Duong Trieu Trieu ; Hai Tien Le ; Tam Thanh Nguyen ; The Ngoc Do ; Hoai To Nguyen
Journal of Surgery 2007;57(1):73-79
Background: Gastric cancer is a common disease in the world. For treatment, gastrectomy is still considered as the first choice. However, recovering of postoperative gastrointestinal circulation remains a controversial issue. Objectives: To assess the early results of 2 methods as gastroduodenostomy (Billroth I type) and gastrojejunostomy (Billroth type II) in recovering of gastrointestinal circulation. Subjects and method: A descriptive, retrospective study was conducted on 98 patients (61 males, 37 females, mean aged 48.1\xb112.7), were confirmed diagnosed with gastric cancer, treated in Military Central Hospital N.108 from May, 2001 to December, 2005. Results: Tumor positions were seen in 1/3 lower and 1/3 middle of gastric organ (59.2% and 40.8%, respective). There was no significant difference for invasive level of tumor between 2 groups (P>0.05). 62.2% patients with invasive level of tumor in stage of T4 in both 2 groups. Generally, the lesion between 2 forms of ulcer and rough differed significantly. The patients with and without metastatic lymph nodes were 57 and 41 patients, respective. All of patients were conducted with lymph node dissection at the stage of DIII-DIV. The difference between 2 groups for surgical time was no statistic significant. Conclusion: Billroth type I method combined with lymph nodes dissection was a safe and feasible technique in treatment of gastric cancer.
Stomach Neoplasms/ surgery
;
Gastrectomy
;
Lymph Node Excision
;
10.The surgical accident and complication of the total gastrectomy to treat the gastric cancer.
Journal of Practical Medicine 2002;430(9):33-37
149 patients with gastric epithelioglandular cancer were operated for the total gastrectomy in the Army Central Hospital No 108 from 1/1994 to 1/200 (male: 86; female: 63), average ages: 50, divided 2 groups according to the 2 methods of the different digestive circulation recovering. The results have shown that the rate of the tumors in the determined positions as vertical axis and perimeter of stomach the average size of the tumor, the average duration of operation and the rate of accidents were not different between two groups. The average rate of accident during operation was 6,7%, the rate of surgical complication was 18,1%.There was no death.
Accidents
;
Complications
;
Gastrectomy
;
Stomach Neoplasms
;
surgery
;
therapeutics